Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol PABPN1 contributors: mct/shn - updated : 20-12-2014
HGNC name poly(A) binding protein, nuclear 1
HGNC id 8565
ASSOCIATED DISORDERS
corresponding disease(s) OPMD
Susceptibility
Variant & Polymorphism repeat polyalanine expansion leading to the formation of nuclear aggregates (intranuclear inclusions)
Candidate gene
Marker
Therapy target
  • anti-aggregation therapy (trehalose), reducing aggregate formation, may prove effective in the treatment of OPMD
  • a single-domain intracellular antibody, preventing oculopharyngeal muscular dystrophy-associated aggregation of nuclear polyA-binding protein
  • Sir2 and AMPK inhibition as therapeutic strategies for muscle protection in OPMD
  • Wild-type PABPN1 over-expression can reduce mutant PABPN1 toxicity in both cell and mouse models of OPMD
  • ANIMAL & CELL MODELS
  • Transgenic miceexpressing high levels of expanded hPABPN1 with a 13-alanine stretch showed an apparent myopathy phenotype, especially in old age
  • PABPN1 knockdown makes cells more susceptible to apoptotic stimuli
  • transcriptomic analysis revealed a massive gene deregulation in mouse model of OPMD (A17.1), display a significant deregulation of pathways associated with muscle atrophy